Which has grown faster, AZTA or BCRX?

Over the past five years, BCRX grew revenue faster — AZTA at a 4.82% CAGR versus BCRX at 64.07%.

How have AZTA and BCRX total returns compared?

Over the past 10 years, AZTA delivered 12.81% and BCRX delivered 5.82% annualized total return. Past performance doesn't predict future results.

Azenta, Inc. (AZTA) vs BioCryst Pharmaceuticals, Inc. (BCRX)

A side-by-side comparison of Azenta, Inc. and BioCryst Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AZTA

Azenta, Inc.

$1.85B

$40.11HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

BCRX

BioCryst Pharmaceuticals, Inc.

$2.04B

$8.03HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — AZTA vs BCRX

growth of $100 · dividends reinvested · last 10y

AZTA +237.6% (+12.9%/yr)BCRX +100.5% (+7.2%/yr)AZTA compounded faster over this window

AZTA BCRX

AZTA vs BCRX: by the numbers

•BCRX is the larger company ($2.04B vs $1.85B market cap).
•Both run net losses; AZTA's is the smaller (-20.02% vs -40.90% net margin).
•BCRX grew revenue faster over the past five years (64.07% vs 4.82% CAGR).

Metrics side by side

Valuation

Metric	AZTA	BCRX
Forward P/E	80.76	N/A
P/S ratio	3.01	2.17
P/B ratio	1.22	N/A
EV / EBITDA	50.03	N/A
FCF yield	0.53%	17.50%

Profitability

Metric	AZTA	BCRX
Gross margin	44.05%	97.82%
Operating margin	-3.49%	38.98%
Net margin	-20.02%	-40.90%
ROE	-8.14%	N/A
ROIC	-1.33%	-89.73%

Growth (annualized)

Metric	AZTA	BCRX
Revenue CAGR (5Y)	4.82%	64.07%
Total return CAGR (5Y)	-15.91%	-10.02%

Frequently asked

Which has grown faster, AZTA or BCRX?: Over the past five years, BCRX grew revenue faster — AZTA at a 4.82% CAGR versus BCRX at 64.07%.
How have AZTA and BCRX total returns compared?: Over the past 10 years, AZTA delivered 12.81% and BCRX delivered 5.82% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZTA analysis Full BCRX analysis Interactive comparison tool

Dig into the metrics

Azenta ROE BioCryst Pharmaceuticals ROE Azenta operating margin BioCryst Pharmaceuticals operating margin Azenta revenue growth BioCryst Pharmaceuticals revenue growth Azenta free cash flow BioCryst Pharmaceuticals free cash flow

Azenta & BioCryst Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.